Skip to content
HowShorted

SOLENO THERAPEUTICS INC short interest in 2022

In 2022, SOLENO THERAPEUTICS INC's disclosed short interest ran from 0.64% of shares outstanding on 14 Jan 2022 to 1.21% on 15 Dec 2022, a change of +0.57 percentage points. The year's high was 1.46% on 29 Jul 2022 and its low 0.28% on 13 May 2022, averaging 0.72% across 18 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.02 days on 15 Feb 2022. Full history: SOLENO THERAPEUTICS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SOLENO THERAPEUTICS INC in 2022

2022 in figures

Start of year
0.64% (14 Jan 2022)
End of year
1.21% (15 Dec 2022)
Change
+0.57 pp
High
1.46% (29 Jul 2022)
Low
0.28% (13 May 2022)
Average
0.72%
Highest days to cover
6.02 (15 Feb 2022)
SEC filings marked
8

Every report in 2022

SOLENO THERAPEUTICS INC short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20220.64%2.13
31 Jan 20220.64%1.91
15 Feb 20220.71%6.02
28 Feb 20220.70%4.11
15 Mar 20220.63%2.17
31 Mar 20220.75%1.00results (8-K), 10-K filed
14 Apr 20220.47%1.00
29 Apr 20220.35%1.00
13 May 20220.28%1.0010-Q filed, results (8-K)
31 May 20220.38%1.00
15 Jun 20220.43%1.00
30 Jun 20221.03%1.00
15 Jul 20220.89%1.00
29 Jul 20221.46%1.00
15 Aug 20220.66%1.0010-Q filed, results (8-K)
15 Nov 20220.64%1.1110-Q filed, results (8-K)
30 Nov 20221.06%1.00
15 Dec 20221.21%2.25

See also: SOLENO THERAPEUTICS INC's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.